Effects of combining immune checkpoint inhibitors and anti-angiogenic agents on bone metastasis in non-small cell lung cancer patients

This study aimed to evaluate the efficacy of combining immune checkpoint inhibitors (ICIs) and anti-angiogenic agents in treating lung cancer patients with bone metastases (BMs), as it is unclear whether this combination is effective for this condition. Non-small cell lung cancer patients with BMs r...

Descripción completa

Detalles Bibliográficos
Autores principales: Xie, Xiaohong, Zhou, Maolin, Wang, Liqiang, Wang, Fei, Deng, Haiyi, Yang, Yiling, Sun, Ni, Li, Ru, Chen, Ying, Lin, Xinqing, Liu, Ming, Zhou, Chengzhi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Taylor & Francis 2023
Materias:
Immunotherapy - Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395206/
https://www.ncbi.nlm.nih.gov/pubmed/37526078
http://dx.doi.org/10.1080/21645515.2023.2241310

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10395206/
https://www.ncbi.nlm.nih.gov/pubmed/37526078
http://dx.doi.org/10.1080/21645515.2023.2241310

Ejemplares similares